Rapport Therapeutics (RAPP) News Today $19.71 -1.33 (-6.32%) (As of 10/8/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% - Here's WhyOctober 4, 2024 | americanbankingnews.comRapport Therapeutics (NASDAQ:RAPP) Trading Up 7% - Here's What HappenedOctober 4, 2024 | americanbankingnews.comRapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.1%October 2, 2024 | marketbeat.comLogos Global Management LP Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP)Logos Global Management LP acquired a new stake in Rapport Therapeutics (NASDAQ:RAPP - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 208,910 shares of the company's stock, valued at approximately $4,859,000. Logos Global ManagemOctober 1, 2024 | marketbeat.comPerceptive Advisors LLC Invests $17.40 Million in Rapport Therapeutics (NASDAQ:RAPP)Perceptive Advisors LLC bought a new stake in shares of Rapport Therapeutics (NASDAQ:RAPP - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The fund bought 748,183 shares of the company's stock, valued at approximately $17,403,000. Perceptive Advisors LLC owneSeptember 30, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Up 6.2%September 29, 2024 | americanbankingnews.comRapport Therapeutics (NASDAQ:RAPP) Shares Up 6.2%Rapport Therapeutics (NASDAQ:RAPP) Trading 6.2% HigherSeptember 27, 2024 | marketbeat.comARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP)ARCH Venture Management LLC bought a new stake in shares of Rapport Therapeutics (NASDAQ:RAPP - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 3,728,738 shares of the company's stock, valued at approximately $86,730,000. Rapport TheSeptember 24, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Down 2.4%Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 2.4%September 19, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Shares Up 4.7%Rapport Therapeutics (NASDAQ:RAPP) Trading Up 4.7%September 17, 2024 | marketbeat.comSofinnova Investments Inc. Buys Shares of 1,951,562 Rapport Therapeutics (NASDAQ:RAPP)Sofinnova Investments Inc. acquired a new stake in Rapport Therapeutics (NASDAQ:RAPP - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,951,562 shares of the company's stock, valued atSeptember 17, 2024 | marketbeat.comRapport semestriel Pilier 3 - 30 juin 2024September 17, 2024 | globenewswire.comRapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00September 16, 2024 | marketbeat.comJohnson & Johnson Invests $58.11 Million in Rapport Therapeutics (NASDAQ:RAPP)Johnson & Johnson acquired a new stake in Rapport Therapeutics (NASDAQ:RAPP - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,498,051 shares of the company's stock, valued at approximately $58,105,000. RapportSeptember 16, 2024 | marketbeat.comTD Asset Management Inc Invests $2.36 Million in Rapport Therapeutics (NASDAQ:RAPP)TD Asset Management Inc bought a new position in Rapport Therapeutics (NASDAQ:RAPP - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 101,522 shares of the company's stock, valued at approximately $2,361,000. TD AsSeptember 13, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Down 5.5%Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.5%September 11, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20September 5, 2024 | marketbeat.comRapport Therapeutics to Present at Upcoming Epilepsy Medical ConferencesSeptember 5, 2024 | globenewswire.comRapport Therapeutics (NASDAQ:RAPP) Trading 5.8% Higher Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.8%September 4, 2024 | marketbeat.comRapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry SummitAugust 29, 2024 | globenewswire.comRapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40August 28, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.4%Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.4%August 27, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading 3.8% Higher Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 3.8%August 26, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading 2.5% Higher Rapport Therapeutics (NASDAQ:RAPP) Shares Up 2.5%August 20, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Down 2.5%Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.5%August 15, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Up 10.2%Rapport Therapeutics (NASDAQ:RAPP) Trading Up 10.2%August 13, 2024 | marketbeat.comThe 3 Best Healthcare Stocks to Buy in August 2024August 12, 2024 | investorplace.comRAPP Stock Earnings: Rapport Therapeutics Misses EPS for Q2 2024August 10, 2024 | investorplace.comRapport Therapeutics (NASDAQ:RAPP) Sets New 12-Month Low at $16.80Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year Low at $16.80August 8, 2024 | marketbeat.com3 Under-The-Radar Healthcare Stocks to Buy for Outsized ReturnsAugust 6, 2024 | investorplace.comRapport Therapeutics (NASDAQ:RAPP) Shares Down 10.7% Rapport Therapeutics (NASDAQ:RAPP) Shares Down 10.7%August 5, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Up 3%Rapport Therapeutics (NASDAQ:RAPP) Trading 3% HigherAugust 2, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.9%Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.9%July 30, 2024 | marketbeat.comRapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainJuly 29, 2024 | globenewswire.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Up 11%Rapport Therapeutics (NASDAQ:RAPP) Trading 11% HigherJuly 23, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $23.03Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $23.03July 19, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Hits New 52-Week High at $28.08Rapport Therapeutics (NASDAQ:RAPP) Reaches New 12-Month High at $28.08July 17, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Up 5.2%Rapport Therapeutics (NASDAQ:RAPP) Shares Up 5.2%July 15, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Reaches New 52-Week High at $27.14Rapport Therapeutics (NASDAQ:RAPP) Hits New 1-Year High at $27.14July 11, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Down 6.5%Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%July 10, 2024 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Shares Up 6%Rapport Therapeutics (NASDAQ:RAPP) Shares Up 6%July 9, 2024 | marketbeat.comHedge Fund and Insider Trading News: Bill Ackman, Segantii Capital Management Ltd, Rapport Therapeutics Inc (RAPP), Archer Aviation Inc (ACHR), and MoreJuly 5, 2024 | insidermonkey.comRapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $23.30Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $23.30July 5, 2024 | marketbeat.comJames Healy Purchases 44,032 Shares of Rapport Therapeutics (NASDAQ:RAPP) StockJuly 4, 2024 | insidertrades.comJames Healy Acquires 44,032 Shares of Rapport Therapeutics (NASDAQ:RAPP) StockRapport Therapeutics (NASDAQ:RAPP - Get Free Report) Director James Healy acquired 44,032 shares of the stock in a transaction dated Monday, July 1st. The stock was bought at an average price of $24.52 per share, for a total transaction of $1,079,664.64. Following the completion of the purchase, the director now owns 40,851 shares in the company, valued at approximately $1,001,666.52. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.July 3, 2024 | marketbeat.com Get Rapport Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RAPP and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s chilling warning for humanity (Ad)The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life. Go here to see why. RAPP Media Mentions By Week RAPP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RAPP News Sentiment▼0.380.49▲Average Medical News Sentiment RAPP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RAPP Articles This Week▼43▲RAPP Articles Average Week Get Rapport Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RAPP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PTCT News Today MOR News Today MRUS News Today IOVA News Today PTGX News Today TWST News Today IBRX News Today ACAD News Today AMRX News Today AGIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RAPP) was last updated on 10/8/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPP Stock Alerts